ArticleVaccines2021

Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells.

Kevin Lenogue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.